Palisade Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-373,462
Closed -$13.6M 402
2020
Q3
$13.6M Sell
373,462
-59,571
-14% -$2.22M 0.4% 90
2020
Q2
$16.3M Buy
433,033
+2,513
+0.6% +$101K 0.52% 63
2020
Q1
$15.8M Buy
430,520
+20,200
+5% +$785K 0.56% 52
2019
Q4
$16.6M Buy
410,320
+1,674
+0.4% +$62.4K 0.47% 74
2019
Q3
$14.2M Buy
408,646
+28,144
+7% +$927K 0.43% 77
2019
Q2
$12.1M Buy
380,502
+19,838
+6% +$590K 0.37% 90
2019
Q1
$10.8M Buy
360,664
+15,496
+4% +$444K 0.35% 95
2018
Q4
$10.7M Sell
345,168
-27,055
-7% -$987K 0.39% 81
2018
Q3
$14.1M Sell
372,223
-26,084
-7% -$987K 0.39% 80
2018
Q2
$15.3M Buy
398,307
+71,354
+22% +$2.41M 0.44% 74
2018
Q1
$11M Buy
326,953
+73,987
+29% +$2.84M 0.37% 92
2017
Q4
$11.2M Buy
252,966
+33,193
+15% +$1.51M 0.38% 80
2017
Q3
$11M Buy
219,773
+76,699
+54% +$3.92M 0.39% 81
2017
Q2
$7.56M Buy
+143,074
New +$7.67M 0.28% 117

Other funds holding PBH

Palisade Capital Management's PBH Position: Q4 2020 in Review

Palisade Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q4 2020, closing a stake of 373,462 shares — an estimated $13.6M sold.

Palisade Capital Management first reported a position in PBH in Q2 2017 and held it in 14 quarters. The position peaked at $16.6M in Q4 2019. 237 funds tracked by Wall St. Rank hold PBH as of Q4 2020.

  • Palisade Capital Management reported no remaining Prestige Consumer Healthcare position as of Q4 2020 after selling out during the quarter.
  • Palisade Capital Management sold 373,462 Prestige Consumer Healthcare shares in Q4 2020, an estimated $13.6M.
  • Palisade Capital Management first reported a position in Prestige Consumer Healthcare in Q2 2017 and held it in 14 quarters.
  • Palisade Capital Management's Prestige Consumer Healthcare position peaked at $16.6M in Q4 2019.
  • 237 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2020.

Based on Palisade Capital Management's 13F filing for Q4 2020, filed 11 Feb 2021.